1 2 3 4 5 6

читать далее ... prehensive risk reduction to patients with coronary and other vascular diseases J Am Coil Cardiol 1995 26 293-295 3 HulleySB Grady D BushT etal Randomized trial otestrogen plus progestm for secondary prevention of coronary heart disease in postmenopausal women JAMA 1998 280 605 - 613 4 Lewis SJ etal Women in CARE have earlier and greater response to pravastatm post myocardial infarction Circulation 1996 94 (SuppI I) 1-12 Abstract 5 Scandinavian Simvastatm Survival Study Group Randomized trial of cholesterol low enng in 4444 patients with coronary heart disease the Scandinavian Simvastatm Survival Study (4S) Lancet 1994 344 1383 - 1389 6 Downs M J Clearfield M Weis S et al Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol level Results of AFCAPS/TexCAPS JAMA 1998 279 1615 - 1622 7 Wood D Durnngton P IV Poulter N et al Joint British Recommendations on pre vention of coronary heart disease in clinical practice on behalf of the British Cardiac society British Hyperlipidemia Association British Hypertension Society and endorsed by the British Diabetic Association Heart 1998 80 (Supply) S1-S29 8 American College of Physicians Guidelines for counselling postmenopausal women about preventive hormone therapy Ann Intern Med 1992 117 117-128 9 GilliganDM QuyyumiAA Cannon R 0 III etal Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women Circulation 1994 89 2545-2551 10 Hernngton DM Braden GA, Williams J К, Morgan TM Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estro gen replacement therapy Am J Cardiol 1994 73 951-952 11 NabulsiAA FolsomAR White A et al Association of hormone-replacement ther ару with various cardiovascular risk factors in postmenopausal women The Atherosclerosis Risk in Communities Study Investigators New Eng J Med 1993 328 1069-1075 12 Soma M Fumagalli R Paoletti R et al Plasma Lp(a) concentration after estrogen and progestagen in postmenopausal women Lancet, 1991,337 612 13 WalshBW Schiff I Rosner В et al Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins N Eng J Med 1991, 325 1196-1204 14 Darling GM Johns J A McCloudPI etal Estrogen and progestm compared with sim vastatm for hypercholesterolemia in postmenopausal women l\l EngI J Med 1997 337 595-601 15 LaRosaJC Metabolic effects of estrogens and progestins Fertil StenI, 1994, 62 (SuppI 2) 140S-146S 16 IVIiettmen Т A etal Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectons Findings from the Scandinavian Simvastatm Survival Study (4S) Circulation 1997 96 4211-4218 17 Pines A Levo Y Ayalon D Hormone replacement therapy compared with simvastatm for postmenopausalwomen with hypercholesterolemia N EngI J Med, 1998,338 63 18 Sack M IV etal Oestrogen and inhibition of oxidation of low density lipoproteins in postmenopausal women Lancet 1994 Источник: Лякишев А.А. Русский медицинский журнал. 2001. Т.9. №9. С.362-365